Skip to main content
Have a personal or library account? Click to login
Association Between the Albumin-Bilirubin (ALBI) Score and All-cause Mortality Risk in Intensive Care Unit Patients with Heart Failure Cover

Association Between the Albumin-Bilirubin (ALBI) Score and All-cause Mortality Risk in Intensive Care Unit Patients with Heart Failure

By: Jiuyi Wang,  Kai Wang,  Guibo Feng and  Xin Tian  
Open Access
|Dec 2024

References

  1. Becher PM, Lund LH, Coats AJS, Savarese G. An update on global epidemiology in heart failure. Eur Heart J. 2022; 43:30053007. DOI: 10.1093/eurheartj/ehac248
  2. Foroutan F, Rayner DG, Ross HJ, Ehler T, Srivastava A, Shin S, et al. Global Comparison of Readmission Rates for Patients With Heart Failure. J Am Coll Cardiol. 2023; 82:430444. DOI: 10.1016/j.jacc.2023.05.040
  3. El Hadi H, Di Vincenzo A, Vettor R, Rossato M. Relationship between Heart Disease and Liver Disease: A Two-Way Street. Cells. 2020; 9. DOI: 10.3390/cells9030567
  4. Harjola VP, Mullens W, Banaszewski M, Bauersachs J, Brunner-La Rocca HP, Chioncel O, et al. Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2017; 19:821836. DOI: 10.1002/ejhf.872
  5. Xanthopoulos A, Starling RC, Kitai T, Triposkiadis F. Heart Failure and Liver Disease: Cardiohepatic Interactions. JACC Heart Fail. 2019; 7:8797. DOI: 10.1016/j.jchf.2018.10.007
  6. Allen LA, Felker GM, Pocock S, McMurray JJ, Pfeffer MA, Swedberg K, et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail. 2009; 11:170177. DOI: 10.1093/eurjhf/hfn031
  7. Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015; 33:550558. DOI: 10.1200/jco.2014.57.9151
  8. Tian BW, Yan LJ, Ding ZN, Liu H, Han CL, Meng GX, et al. Evaluating liver function and the impact of immune checkpoint inhibitors in the prognosis of hepatocellular carcinoma patients: A systemic review and meta-analysis. Int Immunopharmacol. 2023; 114:109519. DOI: 10.1016/j.intimp.2022.109519
  9. Toyoda H, Johnson PJ. The ALBI score: From liver function in patients with HCC to a general measure of liver function. JHEP Rep. 2022; 4:100557. DOI: 10.1016/j.jhepr.2022.100557
  10. Chen JH, Zhang LW, Lin ZJ, Chen XF, Chen LC, Wang CX, et al. The Association Between the Albumin-Bilirubin Score and Contrast-Associated Acute Kidney Injury in Patients Undergoing Elective Percutaneous Coronary Intervention. Angiology. 2024; 33197241228051. DOI: 10.1177/00033197241228051
  11. Duman ZM, Timur B. Albumin-Bilirubin Score: A Novel Mortality Predictor in Valvular Surgery. Braz J Cardiovasc Surg. 2023; 38:271277. DOI: 10.21470/1678-9741-2022-0008
  12. Johnson AEW, Bulgarelli L, Shen L, Gayles A, Shammout A, Horng S, et al. MIMIC-IV, a freely accessible electronic health record dataset. Sci Data. 2023; 10:1. DOI: 10.1038/s41597-022-01899-x
  13. Kudo M. Newly Developed Modified ALBI Grade Shows Better Prognostic and Predictive Value for Hepatocellular Carcinoma. Liver Cancer. 2022; 11:18. DOI: 10.1159/000521374
  14. Yamashita Y, Umemura T, Kimura T, Joshita S, Hirohara J, Nakano T, et al. Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis. JHEP Rep. 2023; 5:100662. DOI: 10.1016/j.jhepr.2022.100662
  15. Qiao P, Li L, Ruan H, Zhang M, Wang Z, Li X, et al. Application of the ALBI Scoring System for Mortality Outcome Prediction in Patients with Hypertrophic Cardiomyopathy. Glob Heart. 2022; 17:73. DOI: 10.5334/gh.1163
  16. Jiang M, Wei XB, Huang JL, Su ZD, Lin YW, Yu DQ. Albumin-Bilirubin Score to Predict Outcomes in Patients with Idiopathic Dilated Cardiomyopathy. Arq Bras Cardiol. 2022; 118:11081115. DOI: 10.36660/abc.20210035
  17. Luo Y, Li Z, Liu J, Chong Y, Wu B. Prognostic value of the albumin-bilirubin score in critically ill patients with heart failure. Ann Palliat Med. 2021; 10:1272712741. DOI: 10.21037/apm-21-3424
  18. Han S, Wang C, Tong F, Li Y, Li Z, Sun Z, et al. Prognostic impact of albumin-bilirubin score on the prediction of in-hospital mortality in patients with heart failure: a retrospective cohort study. BMJ Open. 2022; 12:e049325. DOI: 10.1136/bmjopen-2021-049325
  19. Maack C, Eschenhagen T, Hamdani N, Heinzel FR, Lyon AR, Manstein DJ, et al. Treatments targeting inotropy. Eur Heart J. 2019; 40:36263644. DOI: 10.1093/eurheartj/ehy600
  20. Ahmad T, Miller PE, McCullough M, Desai NR, Riello R, Psotka M, et al. Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials. Eur J Heart Fail. 2019; 21:10641078. DOI: 10.1002/ejhf.1557
  21. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2000; 35:681689. DOI: 10.1016/s0735-1097(99)00608-7
  22. Tromp J, Paniagua SMA, Lau ES, Allen NB, Blaha MJ, Gansevoort RT, et al. Age dependent associations of risk factors with heart failure: pooled population based cohort study. Bmj. 2021; 372:n461. DOI: 10.1136/bmj.n461
  23. Møller S, Bernardi M. Interactions of the heart and the liver. Eur Heart J. 2013; 34:28042811. DOI: 10.1093/eurheartj/eht246
  24. Soppert J, Kraemer S, Beckers C, Averdunk L, Möllmann J, Denecke B, et al. Soluble CD74 Reroutes MIF/CXCR4/AKT-Mediated Survival of Cardiac Myofibroblasts to Necroptosis. J Am Heart Assoc. 2018; 7:e009384. DOI: 10.1161/jaha.118.009384
  25. Davenport A, Sheikh MF, Lamb E, Agarwal B, Jalan R. Acute kidney injury in acute-on-chronic liver failure: where does hepatorenal syndrome fit? Kidney Int. 2017; 92:10581070. DOI: 10.1016/j.kint.2017.04.048
  26. Simonetto DA, Gines P, Kamath PS. Hepatorenal syndrome: pathophysiology, diagnosis, and management. Bmj. 2020; 370:m2687. DOI: 10.1136/bmj.m2687
DOI: https://doi.org/10.5334/gh.1379 | Journal eISSN: 2211-8179
Language: English
Submitted on: May 15, 2024
Accepted on: Nov 28, 2024
Published on: Dec 19, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2024 Jiuyi Wang, Kai Wang, Guibo Feng, Xin Tian, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.